ESC 365 - Prognostic value of different biomarkers in a cohort of patients with diastolic dysfunction and heart failure with preserved ejection fraction.

ESC Premium Access

Prognostic value of different biomarkers in a cohort of patients with diastolic dysfunction and heart failure with preserved ejection fraction.

Session: Poster session 5 - Chronic heart failure (CHF)

Topic: Prognosis

Speaker: Doctor L. Schleussner (Dresden, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Leonhard Schleussner

Heart Center - University Hospital Dresden, Dresden (Germany)

0 follower

31 more presentations in this session

Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling.

Speaker: Doctor C. Santos-Gallego (New York, US)

Iron status, respiratory muscle strength, and physical fitness in men with heart failure with reduced ejection fraction

Speaker: Doctor M. Drozd (Wroclaw, PL)

Glycer-AGEs is associated with the severity of cardiac function of diabetic cardiomyopathy(DbCM).

Speaker: Assistant Professor H. Aoki (Uchinada, JP)

Added-on trimetazidine could lower the risk of incidental left ventricular dysfunction +/- heart failure in epirubicinum recipients for bladder cancer

Speaker: Associate Professor A. Tase (Pitesti, RO)

Early, combined heart failure therapy attenuates doxorubicin cardiomyopathy in rats

Speaker: Miss M. Lodi (Debrecen, HU)

Access the full session

Poster session 5 - Chronic heart failure (CHF)

Speakers: Doctor L. Schleussner, Doctor C. Santos-Gallego, Doctor M. Drozd, Assistant Professor H. Aoki, Associate Professor A. Tase...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources